Related Experiment Video
Updated: Apr 19, 2026
Thermal Preconditioning During Ex-vivo Lung Perfusion for the Rehabilitation of Damaged Lung Grafts before Transplantation
Published on: October 31, 2025
Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor gene ECRG4
Steven Kao1, Ashkaun Shaterian, David M Cauvi
1Department of Surgery Division of Trauma, Surgical Critical Care, Burn and Acute Care Surgery, School of Medicine, University of California in San Diego, La Jolla, California, USA.
Purpose:
The human c2orf40 gene encodes a candidate tumor suppressor called Esophageal Cancer-Related Gene-4 (ECRG4) that is a cytokine-like epigenetically-regulated protein that is characteristically downregulated in cancer, injury, inflammation, and infection. Here, we asked whether ECRG4 gene expression is detectable in lung epithelial cells and if its expression changes with inflammation, infection, and/or protective preconditioning.
Materials And Methods:
We used immunoblotting, PCR, and quantitative PCR to measure ECRG4 and either inhalation anesthesia preconditioning, lipopolysaccharide injection, or laparotomy to modulate lung inflammation.
Results:
Immunoblotting establishes the presence of the full-length 14 kDa ECRG4 peptide in mouse lung. Immunohistochemistry localizes ECRG4 to type l alveolar epithelial cells. Basal ECRG4 mRNA is greater than TNF-α, IL-1β, and IL-6 but following inflammatory lung injury, TNF-α, IL-1β, IL-6, and IL-10 are upregulated while ECRG4 gene expression is decreased. Similar findings are observed after an intravenous administration of lipopolysaccharide. In contrast, lung preconditioning with isoflurane anesthesia increases lung ECRG4 gene expression. Over-expression of ECRG4 in human lung epithelial cells in vitro decreases cell proliferation implying that a loss of ECRG4 in vivo would be permissive to cell growth.
Conclusions:
This study supports the hypothesis that ECRG4 acts as a sentinel growth inhibitor in lung alveolar epithelial cells. Its downregulation by injury, infection, and inflammation and upregulation by preconditioning supports a role for ECRG4 in regulating the alveolar epithelium response to injury and inflammation. By extension, the findings support a functional consequence to its inhibition by promoter hypermethylation (i.e. lung cancer) and suggest potential benefits to its upregulation.
Insights
Esophageal Cancer-Related Gene-4 (ECRG4) is present in lung cells and decreases proliferation. Its expression is reduced by inflammation and infection but increased by anesthesia, suggesting a role in lung injury response.
Area of Science:
- Molecular biology
- Cell biology
- Pulmonary medicine
Background:
- The Esophageal Cancer-Related Gene-4 (ECRG4) is a candidate tumor suppressor protein.
- ECRG4 is epigenetically regulated and downregulated in various cancers, injury, inflammation, and infection.
- Its role in lung epithelial cells and response to inflammatory stimuli is not well understood.
Purpose of the Study:
- To determine if ECRG4 gene expression is detectable in lung epithelial cells.
- To investigate how ECRG4 expression changes in response to lung inflammation, infection, and preconditioning.
- To explore the functional implications of ECRG4 in lung epithelial cell proliferation.
Main Methods:
- Immunoblotting, PCR, and quantitative PCR were used to measure ECRG4 expression.
- Lung inflammation was induced by lipopolysaccharide injection or laparotomy.
- Protective preconditioning was achieved using inhalation anesthesia (isoflurane).
Main Results:
- Full-length ECRG4 peptide (14 kDa) was detected in mouse lung, localized to type I alveolar epithelial cells.
- Basal ECRG4 mRNA levels were higher than inflammatory markers (TNF-α, IL-1β, IL-6).
- Inflammatory lung injury and lipopolysaccharide administration decreased ECRG4 expression, while isoflurane anesthesia increased it.
- Overexpression of ECRG4 in vitro reduced lung epithelial cell proliferation.
Conclusions:
- ECRG4 functions as a sentinel growth inhibitor in lung alveolar epithelial cells.
- Downregulation of ECRG4 by injury and inflammation suggests a role in regulating the alveolar epithelium's response.
- Upregulation of ECRG4 by preconditioning and its growth-inhibitory function support potential benefits in lung cancer and injury contexts.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
01:23Chronic Obstructive Pulmonary Disease I: Introduction
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-I: Introduction